Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AATK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ABCA13 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ABHD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | AC002310.11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | AC002310.13 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AC004076.9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | AC005281.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |